Composition of a VEGF antagonist and an anti-proliferative agent and its use for the treatment of cancer
Details for Australian Patent Application No. 2004261165 (hide)
International Classifications
Event Publications
12 January 2006 PCT application entered the National Phase
PCT publication WO2005/011734 Priority application(s): WO2005/011734
16 July 2009 Application Accepted
Published as AU-B-2004261165
20 August 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 30 Jul 2009. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000
17 December 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 30 Jul 2009
24 December 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser